CTRI/2022/02/040171尚未招募2/3 期
CONTROLLED STUDY OF MUSTAKATUKA CHURNA IN RASA RAKTAGAT MEDO DUSHTI W.S.R. TO DYSLIPIDEMIA
Dr Akanksha Dandekar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年2月18日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Controlled study of MustaKatuka churna in rasa raktagat medo dushti w.s.r. to Dyslipidemia
研究概览
简要总结
The present study is the clinical experimental study for completion under D.Y.Patil deemed to be University
Total duration of trials is 1 years
TITLE: Controlled study of Mustakatuka churna in rasa raktagat medo dushti w.s.r. yo dyslipidemia
STUDY GROUP: Sample size 30 will be treated with Mustakatuka churna and 30 will be treated with Atorvastatin
STUDY CENTRE: School of Ayurveda D.Y.Patil Deemed to be University Nerul, NaviMumbai.
PG SCHOLAR: Dr. Akanksha Dandekar
GUIDE: Dr. Kalpana Satpute.
研究设计
- 研究类型
- Interventional
- 分配方式
- Random Number Table
- 盲法
- Open Label
入排标准
- 年龄范围
- 30.00 Year(s) 至 75.00 Year(s)（—）
- 性别
- All
入选标准
- •newly diagnosed dyslipidemia patients Lipid Panel: SR.
- •LIPID PANEL BORDERLINE 1 Total Cholesterol 200 to 293 mg/dl 2 LDL-C 130 to 159 mg /dl 3 HDL-C 35 to 45 mg/dl 4 Triglycerides 150-199 mg/dl.
排除标准
- •Age: <30, >75yrs Pregnant women & lactating mothers. Patients having history of serious cardiac disorders like myocardial infarction, cardiac failure, COPD. Untreated thyroid disorder. Patients having any major illness like uncontrolled diabetes mellitus. Known case of Asthma, neurological disorders, anemia (Hb<10mg/dl). Known case of Renal insufficiency, nephrotic syndrome. Known case of severe Liver diseases. Known case of HIV positive and HbsAg positive patients. Immune compromised patients. Any serious medical and psychological condition subjects will not be included. Blood Lipid profile according to NCEP -According to Adult Treatment Panel SR. NO. LIPID PANEL DESIRABLE HIGH RISK 1 Total Cholesterol < 200 mg /dl >240 mg/dl 2 LDL-C > 130mg/dl 160-189 mg/dl 3 HDL-C.
- •Female < 40 mg/dl < 50 mg/dl 4 Triglycerides >150 mg/dl 200-499 mg/dl.
结局指标
主要结局
Controlled study of MustaKatuka churna in rasa raktagat medo dushti w.s.r. to Dyslipidemia
时间窗: 0 to 45 days
次要结局
- To study the efficacy of mustakatuka churna in management of dyslipidemia(To study the effects of Atorvastatin)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
2 期
TO STUDY THE THE EFFECT OF MUSTAKATUKA CHURNA IN RASIED LIPID LEVELSCTRI/2022/02/040171Dr Akanksha Dandekar
尚未招募
2/3 期
To Assess The Efficacy Of Shunthyadi Kashay In Management Of Mutrakrucchra With Special Reference To Urinary Tract InfectionCTRI/2025/04/084236Dr Smita Yogesh Jadhav80
尚未招募
3 期
A Clinical Study to see the effect of Rudraksa Churna in the Management of High Blood PressureCTRI/2014/08/004814Central Council for Research in Ayurvedic Sciences CCRAS76
尚未招募
3 期
The Benefits of Dugdhika Churna for Managing Childhood KarshyaCTRI/2025/05/086116Self Punam Bhagwan Tupkar70
招募中
不适用
A CLINICAL TRIAL TO STUDY THE EFFECTS OF TIKTAKSHIRA BASTI (MEDICATED MILK ENEMA) AND TIKTAKSHIRA PANA (MEDICATED MILK ORALLY) IN PATIENTS WITH SANDHIVATA OSTEOARTHRITIS KNEE.CTRI/2016/04/006808GOVT AKHANDANAND AYURVED COLLEGE AHMEDABAD30